138 related articles for article (PubMed ID: 1659429)
1. Potency assessment of foot-and-mouth disease vaccines in cattle by means of antibody assays.
Amadori M; Archetti IL; Tollis M; Buonavoglia C; Panina GF
Biologicals; 1991 Jul; 19(3):191-6. PubMed ID: 1659429
[TBL] [Abstract][Full Text] [Related]
2. [Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].
Bengelsdorff HJ
Berl Munch Tierarztl Wochenschr; 1989 Jun; 102(6):193-8. PubMed ID: 2548473
[TBL] [Abstract][Full Text] [Related]
3. Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines.
Smitsaart EN; Zanelli M; Rivera I; Fondevila N; Compaired D; Maradei E; Bianchi T; O'Donnell V; Schudel AA
Prev Vet Med; 1998 Jan; 33(1-4):283-96. PubMed ID: 9500182
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
[TBL] [Abstract][Full Text] [Related]
5. Combined vaccination of cattle against FMD and rabies.
Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection.
McCullough KC; Bruckner L; Schaffner R; Fraefel W; Müller HK; Kihm U
Vet Microbiol; 1992 Feb; 30(2-3):99-112. PubMed ID: 1313624
[TBL] [Abstract][Full Text] [Related]
7. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
Alonso A; Darsie GC; Teixeira AC; Reis JL; Mesquita JA
Vaccine; 1994 Jun; 12(8):682-6. PubMed ID: 8091844
[TBL] [Abstract][Full Text] [Related]
8. Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant.
Sadir AM; Zamorano PI; Romera A; Wigdorovitz A; Smitsaart E; Marangunich L; Schiappacassi C; Borca MV
Vet Immunol Immunopathol; 1999 Jul; 69(1):11-22. PubMed ID: 10490231
[TBL] [Abstract][Full Text] [Related]
9. [Seasonal variations in the formation of virus-neutralizing antibodies in cattle after vaccination against foot-and-mouth disease].
Felfe P; Thalmann G; Kreienbrink G; Schiele K
Arch Exp Veterinarmed; 1990; 44(2):199-204. PubMed ID: 2167046
[TBL] [Abstract][Full Text] [Related]
10. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application.
van Maanen C
Vet Microbiol; 1990 Aug; 24(2):179-91. PubMed ID: 2173249
[TBL] [Abstract][Full Text] [Related]
11. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
[TBL] [Abstract][Full Text] [Related]
12. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge.
Pay TW; Hingley PJ
Vaccine; 1992; 10(10):699-706. PubMed ID: 1326146
[TBL] [Abstract][Full Text] [Related]
13. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina.
Periolo OH; Seki C; Grigera PR; Robiolo B; Fernández G; Maradei E; D'Aloia R; La Torre JL
Vaccine; 1993; 11(7):754-60. PubMed ID: 8393607
[TBL] [Abstract][Full Text] [Related]
14. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
[TBL] [Abstract][Full Text] [Related]
15. Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays.
Espinoza AM; Maradei E; Mattion N; Cadenazzi G; Maddonni G; Robiolo B; La Torre J; Bellinzoni R; Smitsaart E
Vaccine; 2004 Nov; 23(1):69-77. PubMed ID: 15519709
[TBL] [Abstract][Full Text] [Related]
16. Mouse model as an efficacy test for foot-and-mouth disease vaccines.
Gnazzo V; Quattrocchi V; Soria I; Pereyra E; Langellotti C; Pedemonte A; Lopez V; Marangunich L; Zamorano P
Transbound Emerg Dis; 2020 Nov; 67(6):2507-2520. PubMed ID: 32320534
[TBL] [Abstract][Full Text] [Related]
17. Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.
Lavoria MÁ; Di-Giacomo S; Bucafusco D; Franco-Mahecha OL; Pérez-Filgueira DM; Capozzo AV
Vaccine; 2012 Nov; 30(48):6845-50. PubMed ID: 23000129
[TBL] [Abstract][Full Text] [Related]
18. [Detection of neutralizing antibodies in calves after single vaccination against foot-and-mouth disease virus type ASIA 1 in the field].
Dimitriadis I; Chondrokouki E
Berl Munch Tierarztl Wochenschr; 1991 Sep; 104(9):313-6. PubMed ID: 1659374
[TBL] [Abstract][Full Text] [Related]
19. Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.
Lubroth J; López A; Ramalho AK; Meyer RF; Brown F; Darsie GC
Vet Q; 1998; 20 Suppl 2():S13-7. PubMed ID: 9652056
[TBL] [Abstract][Full Text] [Related]
20. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
